Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License

Contributed by: GlobeNewswire

Tags

Germany

More Like This

Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations

Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities

Tilray Expands Medical Cannabis Portfolio in Germany

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings

Tilray Medical Applauds German Bundestag and Landmark Passage of Medical Cannabis Act in Germany

Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization

Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains